Atlas Trials

Glucagon-like Peptide 1

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glucagon-like Peptide 1

RecordFirmDate
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues (NCT03204396)University Hospital, Basel, Switzerland2017-06-26
Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention (NCT02846168)Chinese PLA General Hospital2016-04-01
Effect of LIXIsenatide on the Renal System (NCT02276196)Amsterdam UMC, location VUmc2014-09-01
Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction (NCT03314844)Chinese PLA General Hospital2013-02-01
Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction (NCT03129594)Chinese PLA General Hospital2013-02-01
Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus (NCT01689051)University Hospital, Gentofte, Copenhagen2012-03-01
Effects of Exendin(9-39) on Gastroduodenal Motility (NCT00468091)Ludwig-Maximilians - University of Munich1999-02-01

Track Glucagon-like Peptide 1 automatically

Every clearance here is in the API, with alerts when new ones post.